Viewing Study NCT02663908


Ignite Creation Date: 2025-12-26 @ 10:57 AM
Ignite Modification Date: 2026-02-26 @ 11:14 AM
Study NCT ID: NCT02663908
Status: TERMINATED
Last Update Posted: 2022-06-29
First Post: 2016-01-22
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Trial Comparing Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Advanced Prostate Cancer and Cardiovascular Disease
Sponsor: Ferring Pharmaceuticals
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2016-04-19
Start Date Type: ACTUAL
Primary Completion Date: 2021-03-29
Primary Completion Date Type: ACTUAL
Completion Date: 2021-03-29
Completion Date Type: ACTUAL
First Submit Date: 2016-01-22
First Submit QC Date: None
Study First Post Date: 2016-01-26
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2022-03-21
Results First Submit QC Date: None
Results First Post Date: 2022-06-29
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2022-06-28
Last Update Post Date: 2022-06-29
Last Update Post Date Type: ACTUAL